Protective effect of the edible brown algaEcklonia stoloniferaon doxorubicin-induced hepatotoxicity in primary rat hepatocytes

Protective Effects of Berberine on Doxorubicin-Induced Hepatotoxicity in Mice

(2012) Xiaoyan Zhao et al.   BIOLOGICAL & PHARMACEUTICAL BULLETIN

Hepatoprotective effects of dieckol-rich phlorotannins from Ecklonia cava, a brown seaweed, against ethanol induced liver damage in BALB/c mice

(2012) Min-Cheol Kang et al.   FOOD AND CHEMICAL TOXICOLOGY

Histopathological effects of cisplatin, doxorubicin and 5-flurouracil (5-FU) on the liver of male albino rats

(2012) Hassan I El-Sayyad et al.   International Journal of Biological Sciences

Isolation and Identification of Phlorotannins from Ecklonia stolonifera with Antioxidant and Hepatoprotective Properties in Tacrine-Treated HepG2 Cells

(2012) Min-Sup Lee et al.   JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY

Anti-inflammatory activity of phlorotannin-rich fermented Ecklonia cava processing by-product extract in lipopolysaccharide-stimulated RAW 264.7 macrophages

(2012) W. A. J. P. Wijesinghe et al.   JOURNAL OF APPLIED PHYCOLOGY

Effect of phlorotannin-rich extracts of Ascophyllum nodosum and Himanthalia elongata (Phaeophyceae) on cellular oxidative markers in human HepG2 cells

(2012) Benoît Quéguineur et al.   JOURNAL OF APPLIED PHYCOLOGY

Doxorubicin: an update on anticancer molecular action, toxicity and novel drug delivery systems

(2012) Oktay Tacar et al.   JOURNAL OF PHARMACY AND PHARMACOLOGY

Bioactive compounds in seaweed: functional food applications and legislation

(2011) Susan Løvstad Holdt et al.   JOURNAL OF APPLIED PHYCOLOGY

Chemical components and its antioxidant properties in vitro: An edible marine brown alga, Ecklonia cava

(2009) Yong Li et al.   BIOORGANIC & MEDICINAL CHEMISTRY

Differentiation of human osteosarcoma cells by isolated phlorotannins is subtly linked to COX-2, iNOS, MMPs, and MAPK signaling: Implication for chronic articular disease

(2009) BoMi Ryu et al.   CHEMICO-BIOLOGICAL INTERACTIONS

Carbonyl Reductase 1 Is a Predominant Doxorubicin Reductase in the Human Liver

(2008) N. Kassner et al.   DRUG METABOLISM AND DISPOSITION